Inconsistent with the result of our work, Kainuma M et al reported that treatment of HCC with OCA treatment promoted EMT phenotypes,34 although FXR may act as a tumour suppressor at the early stage of HCC through the regulation of hepatic inflammatory responses.20 The gene discussed is NR1H4; the disease is hepatocellular carcinoma.